ArticleFrontiers in pharmacology2025

Commentary: Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC.

Xiaoyan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.